{"meta":{"query_hash":"11a2f4e57c3a","filters":{"venue":"Frontiers in Drug Safety and Regulation"},"cohort_total":2,"direct_labels_cover":0,"predictions_cover":2,"exported":2,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/11a2f4e57c3a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Frontiers+in+Drug+Safety+and+Regulation"},"results":[{"id":"W4312173710","doi":"10.3389/fdsfr.2022.1011701","title":"Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective","year":2022,"lang":"en","type":"article","venue":"Frontiers in Drug Safety and Regulation","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Rimouski","funders":"","keywords":"Polypharmacy; Deprescribing; Medicine; Multimorbidity; Intensive care medicine; Adverse effect; Health care; Older people; Drug; Geriatrics; Gerontology; Psychiatry; Chronic disease; Pharmacology","score_opus":0.040531106522615545,"score_gpt":0.36410483222213214,"score_spread":0.3235737256995166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312173710","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044040326,0.6174236,0.0038052578,0.3324538,0.003984322,0.00015205043,0.0001756695,0.000082129314,0.037519086],"genre_scores_gemma":[0.0777932,0.7780172,0.012291618,0.115650155,0.008913356,0.00045358704,0.00025715816,0.000039201226,0.0065844078],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99285465,0.0029547585,0.00064226345,0.00056114123,0.0023379726,0.00064934243],"domain_scores_gemma":[0.9817794,0.008429168,0.0024149243,0.00057553704,0.0050776657,0.0017232923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01530506,0.0006127695,0.00097148214,0.0015270051,0.000924808,0.0055794674,0.0016687465,0.007619789,0.0034423578],"category_scores_gemma":[0.015505024,0.00022117732,0.0009940735,0.0016177747,0.003208796,0.0040790467,0.0021683336,0.007825724,0.0008181063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019516954,0.0006567894,0.0025214076,0.010998577,0.00012239096,0.0007685063,0.0021136687,0.0010146248,0.0031316672,0.16206464,0.09784827,0.7185642],"study_design_scores_gemma":[0.00009435138,0.00079722906,0.004707568,0.018713137,0.00013766655,0.0007815536,0.0012413413,0.00070074113,0.0009886087,0.028166685,0.9435932,0.00007790268],"about_ca_topic_score_codex":0.0022131768,"about_ca_topic_score_gemma":0.0035892292,"teacher_disagreement_score":0.01530506,"about_ca_system_score_codex":0.0026404834,"about_ca_system_score_gemma":0.013084238,"threshold_uncertainty_score":0.080941856},"labels":[],"label_agreement":null},{"id":"W4416841345","doi":"10.3389/fdsfr.2025.1651090","title":"Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices","year":2025,"lang":"en","type":"article","venue":"Frontiers in Drug Safety and Regulation","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Patient Safety Institute","funders":"University of Oxford; Sanofi; Pfizer","keywords":"Pharmacovigilance; Best practice; Vaccination; Pandemic; Excellence; Health care; Public health; Vaccine safety","score_opus":0.14685375948925397,"score_gpt":0.48055328745986664,"score_spread":0.33369952797061264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416841345","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010952008,0.9655796,0.0031038858,0.023682851,0.0011035574,0.00082031015,0.0019766742,0.000067453315,0.0025704796],"genre_scores_gemma":[0.017251985,0.9545747,0.0137880705,0.008868949,0.0009461141,0.0021687117,0.002075736,0.00004648083,0.0002792477],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.85840285,0.052240353,0.054476906,0.006840827,0.026517434,0.0015217372],"domain_scores_gemma":[0.44495526,0.40739045,0.060055465,0.009133369,0.07578154,0.0026839455],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12279385,0.0015566997,0.0047723837,0.057565864,0.001301217,0.0076020476,0.006135355,0.003450356,0.0031823278],"category_scores_gemma":[0.34667695,0.0020784985,0.0060155615,0.04445876,0.0034054143,0.012053132,0.005491305,0.0046495674,0.00089987804],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001188815,0.00006051923,0.0045101764,0.4728904,0.0015168721,0.00017282201,0.0021788562,0.00048475785,0.00021893864,0.00835217,0.031146998,0.47834858],"study_design_scores_gemma":[0.000041883814,0.00012274174,0.0061635547,0.83688164,0.0022138723,0.00029695188,0.0013765569,0.0003273425,0.00030037892,0.0026317565,0.14956269,0.000080629754],"about_ca_topic_score_codex":0.014385127,"about_ca_topic_score_gemma":0.023805156,"teacher_disagreement_score":0.87720615,"about_ca_system_score_codex":0.011036234,"about_ca_system_score_gemma":0.042651933,"threshold_uncertainty_score":0.6494037},"labels":[],"label_agreement":null}]}